| 內容註: |
Discovery and function of the HGF/MET and the MSP/RON kinase signaling pathways in cancer / Silvia Benvenuti, Melissa Milan, and Paolo Comoglio -- The role of HGF/MET and MSP/RON signaling in tumor progression and resistance to anticancer therapy / Lidija Klampfer, Ben Yaw Owusu -- HGF activator (HGFA) and its inhibitors HAI-1 and HAI-2 : key players in tissue repair and cancer / Hiroaki Kataoka and Takeshi Shimomura -- Physiological functions and role of matriptase in cancer / Thomas E. Hyland, Karin List, and Fausto A. Varela -- The cell-surface, transmembrane serine protease hepsin : discovery, function and role in cancer / Denis Belitskin, Juha Klefström, Shishir Pant, and Topi Tervonen -- Targeting HGF with antibodies as an anticancer therapeutic strategy / Donald Bottaro, Dinuka M De Silva, and Arpita Roy -- MET and RON receptor tyrosine kinases as therapeutic antibody targets for cancer / Ling Liu, Mark Wortinger, Jonathan Tetreault, and Nick Loizos -- Inhibitory antibodies of the proteases HGFA, matriptase, and hepsin / Daniel Kirchoffer, Robert Lazarus, and Charles Eigenbrot -- Inhibitors of the growth-factor activating proteases matriptase, hepsin and HGFA : strategies for rational drug design and optimization / Robert Galemmo, James Janetka -- Cyclic peptide serine protease inhibitors based on the natural product SFTI-1 / Ashley Buckle, David E. Hoke, Olga Ilyichova, Blake T. Riley, Jonathan M. Harris -- Screening combinatorial peptide libraries in protease inhibitor drug discovery / Paulina Kasperkiewicz, Marcin Poreba, Sanford Burnham Prebys, Marcin Drag and Wioletta Rut -- Chemical probes targeting proteases for imaging and diagnostics in cancer / Pedro Gonçalves and Steven Verhelst -- Cancer diagnostics of protease activity and metastasis / John Beard and Timothy O'Brien -- Roles of pericellular proteases in tumor angiogenesis : therapeutic implications / Janice Kraniak, Raymond R. Mattingly, and Bonnie Sloane. |